n=10 | |
Population characteristics | |
Age, median in years (IQR) | 73 (69–77) |
Sex (male), n (%) | 10 (100%) |
Hypertension, n (%) | 8 (80%) |
Dyslipidemia, n (%) | 8 (80%) |
Diabetes mellitus type 2, n (%) | 1 (10%) |
Atrial fibrillation, n (%) | 1 (10%) |
Heart disease, n (%) | 2 (20%) |
Current smoker, n (%) | 2 (20%) |
NIHSS on admission, median (IQR) | 1 (0–1) |
Transient ischemic attack, n (%) | 8 (80%) |
Stenosis characteristics | |
V4-segment of vertebral artery, n (%) | 4 (40 %) |
Basilar artery, n (%) | 2 (20 %) |
Distal segment of intracranial carotid artery, n (%) | 4 (40 %) |
Middle cerebral artery, n | 0 |
Pre-interventional stenosis degree according to WASID Study Group, median (IQR) | 78% (75–80%) |
Length of stenosis in mm, median (IQR) | 9 (7–12) |
Mori classification | |
Type A | 10% |
Type B | 70% |
Type C | 20% |
NIHSS, National Institutes of Health Stroke Scale; WASID, Warfarin-Aspirin Symptomatic Intracranial Disease Trial.